NDC 57894-054 – Stelara
Ustekinumab 130 mg/26mL · Solution · Intravenous
Product NDC57894-054
Product details
- Brand name
- Stelara
- Generic name
- Ustekinumab
- Labeler
- Janssen Biotech, Inc.
- Dosage form
- Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761044
- Marketed since
- September 23, 2016
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-12 Antagonist; Interleukin-23 Antagonist
Active ingredients
- Ustekinumab 130 mg/26mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 57894-054-16 sample | 1 VIAL, SINGLE-USE in 1 BOX (57894-054-16) / 26 mL in 1 VIAL, SINGLE-USE | May 1, 2017 |
| 57894-054-27 | 1 VIAL, SINGLE-USE in 1 BOX (57894-054-27) / 26 mL in 1 VIAL, SINGLE-USE | Sep 23, 2016 |